Huons Co., Ltd. Recalls

Overview of recall records associated with Huons Co., Ltd., including dates, categories and classifications where available.

3recall records

Apr 22, 2026latest record date

Apr 22, 2026earliest record date

Recall history in this database

Classification mix: Class II: 3.

DrugApr 22, 2026

Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) recall — FDA D-0530-2026

Lack of Assurance of Sterility

Class IIFDA: OngoingHuons Co., Ltd.

DrugApr 22, 2026

Lidocaine HCl injection, USP, 1% 50mg/5mL (10 mg/mL), 5 mL Single Dose Vials recall — FDA D-0529-2026

Lack of Assurance of Sterility

Class IIFDA: OngoingHuons Co., Ltd.

DrugApr 22, 2026

Lidocaine HCl Injection, USP, 2%, 100 mg/5mL (20 mg/mL), 5 mL Single-Dose Vials recall — FDA D-0532-2026

Lack of Assurance of Sterility

Class IIFDA: OngoingHuons Co., Ltd.

Understanding this recall history

This page summarizes recall records in which the official source identifies Huons Co., Ltd. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.

Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.